Bangladesh’s pharmaceutical industry continues to experience strong market growth in 2026, with the total pharmaceutical market reaching BDT 40,885 crore according to the provided IQVIA MAT Q2 2026 data. The market recorded 10.6% growth, while the four-year compound annual growth Read More …
Category: Pharma News Bangladesh
Top 10 Pharmaceutical Companies in Bangladesh: IQVIA MAT Q1, 2026
Bangladesh’s pharmaceutical industry still remains a fundamental part of the country’s manufacturing economy, displaying notable resilience and competition trends. According to the most recent data available in IQVIA MAT Q1, 2026, the total value of the market is a noteworthy Read More …
Post-Qurbani Beef Health Guide: Manage Digestion & Avoid Bloating
Eid-ul-Adha is full of festivities; however, the increased intake of red meat (beef or mutton) will put considerable stress on your digestion process. The fact is that red meat is rich in proteins and saturated fats, which means it takes Read More …
Strategic Analysis of the Pharmaceutical Employment Landscape in Bangladesh: Corporate Structures, Regulatory Evolution, and Workforce Dynamics
The pharmaceutical industry in Bangladesh has transitioned from a fragmented import-dependent sector to a sophisticated, technology-driven manufacturing powerhouse that accounts for nearly 98% of the domestic drug supply. This industry represents one of the most critical pillars of the national Read More …
Strategic Pharmaceutical Product Management: The 2026 Bangladesh Playbook
The year 2026 marks the most significant transition in the history of the Bangladesh pharmaceutical industry. With the impending graduation from Least Developed Country (LDC) status and the subsequent expiration of the TRIPS waiver, the role of a Product Manager Read More …
Advanced Analytical Frameworks and Market Intelligence: The Architecture of Pharmaceutical Product Management Questionnaires in Bangladesh 2026
The pharmaceutical sector in Bangladesh has reached a stage of industrial maturity in 2026 that necessitates a transition from traditional promotional activities to sophisticated, data-driven market intelligence. With the domestic market valued at approximately US$6 billion and local manufacturers meeting Read More …
Step-by-Step API Indenting Process in Bangladesh Pharmaceutical Industry with Raw Material Sourcing Strategy
This comprehensive guide outlines the step-by-step indenting process for Active Pharmaceutical Ingredients (APIs) in the Bangladesh pharmaceutical industry, alongside a robust sourcing strategy designed for the 2026 market landscape. Part 1: The Step-by-Step API Indenting Process In Bangladesh, the Directorate Read More …
How to Source Pharmaceutical Raw Materials in Bangladesh: API Indenting Process & Supplier Qualification
This comprehensive guide details the structure, regulatory environment, and strategic operations of a pharmaceutical indenting firm in Bangladesh. Given the country’s status as a global generic drug hub, indenting is the “nervous system” that connects over 250 local manufacturers to Read More …
Raw Material Procurement in Bangladesh Pharma: Strategic API Sourcing & DGDA Guide
The pharmaceutical sector in Bangladesh represents a rare and significant triumph of domestic industrial policy within the Global South. Over the five decades following national independence, the country has transitioned from a state of near-total reliance on imported finished medicines Read More …
Explore the most common pharmaceutical deviations in Bangladesh
Explore the most common pharmaceutical deviations in Bangladesh: Learn expert Root Cause Analysis (RCA) techniques and CAPA strategies for DGDA & GMP compliance The pharmaceutical landscape in Bangladesh has evolved from a local manufacturing hub to a sophisticated global exporter. Read More …